Clinical Trials Directory

Trials / Completed

CompletedNCT05061095

Understanding What Matters Most to Patients: Establishing the Validity of a Best-Worst Scaling Survey

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers

Summary

This study will evaluate the validity of using a survey to quantify patient preferences at the point-of-care and the potential effectiveness of the survey to improve goal-concordant care. The primary hypothesis is that by identifying the strength of patient preferences for outcomes with this survey clinicians will be able to improve goal-concordant care by aligning clinical recommendations with patients' preferences. This study will have 50 patients with newly diagnosed hematologic malignancy complete the survey throughout their disease course (up to 2 years) and conduct qualitative interviews with a subset (n = 20) of participants. The information obtained from these participants will be used to refine the survey. Interviews with oncologists and palliative care specialists (up to 10) will inform implementation.

Conditions

Interventions

TypeNameDescription
OTHERAssessment SurveysPatients will complete surveys in three periods. An initial baseline survey, longitudinal assessments completed every 2 weeks over the course of the first three months on study (6 times maximum), and extended assessments that will happen every 3 months after the initial longitudinal period up to 2 years on the study (7 times maximum). Baseline questionnaire will collect demographic and background medical record information. Longitudinal assessments will consist of a BWS questionnaire (patients rate importance of 7 treatment goals), decisional conflict scales, EQ-5D-5L, distress thermometer, and items from PRO-CTCAE. Extended assessments will use same questionnaires as longitudinal assessments.
OTHERQualitative InterviewsPatients will participate in 2 interviews (1 initial interview, 1 follow up). These will be cognitive interviews focusing on establishing content validity for BWS questionnaire. Will establish patient understanding of questions asked in BWS, understanding of how preferences affect treatment decisions, expected outcomes, and feedback from patients on other potentially important attributes not included in BWS.

Timeline

Start date
2022-03-21
Primary completion
2023-09-26
Completion
2023-09-26
First posted
2021-09-29
Last updated
2024-12-27
Results posted
2024-12-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05061095. Inclusion in this directory is not an endorsement.